Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.
Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.
复制标题
DOI:
10.1021/acs.jmedchem.7b00233
复制
发表时间:
2017-05-11
影响因子:
7.3
通讯作者:
Santos WL
中科院分区:
文献类型:
--
作者:
Childress ES;Kharel Y;Brown AM;Bevan DR;Lynch KR;Santos WL
Sphingosine 1-phosphate (S1P) is a pleiotropic signaling molecule that interacts with its five G-protein coupled receptors S1P1-5 to regulate cell growth and survival and has been implicated in a variety of diseases including cancer and sickle cell disease. As the key mediators in the synthesis of S1P, sphingosine kinase (SphK) isoforms 1 and 2 have attracted attention as viable targets for pharmaceutical inhibition. In this report, we describe the design, synthesis, and biological evaluation of aminothiazole-based guanidine inhibitors of SphK. Surprisingly, combining features of reported SphK1 inhibitors generated SphK1/2 dual inhibitor 20l (SLC4011540) (hSphK1 Ki = 120 nM, hSphK2 Ki = 90 nM) and SphK2 inhibitor 20dd (SLC4101431) (Ki = 90 nM, 100-fold SphK2 selectivity). These compounds effectively decrease S1P levels in vitro. In vivo administration of 20dd validated that inhibition of SphK2 increases blood S1P levels.
登录
查看更多内容
影响因子:
2.7
作者:
Leroux FR;Manteau B;Vors JP;Pazenok S
通讯作者:
Pazenok S
影响因子:
7.3
作者:
Baek DJ;MacRitchie N;Anthony NG;Mackay SP;Pyne S;Pyne NJ;Bittman R
通讯作者:
Bittman R
DOI:
10.1126/science.1176709
发表时间:
2009-09-04
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Hait NC;Allegood J;Maceyka M;Strub GM;Harikumar KB;Singh SK;Luo C;Marmorstein R;Kordula T;Milstien S;Spiegel S
通讯作者:
Spiegel S
DOI:
10.1124/jpet.115.225862
发表时间:
2015-10-01
影响因子:
3.5
作者:
Kharel, Yugesh;Morris, Emily A.;Lynch, Kevin R.
通讯作者:
Lynch, Kevin R.
影响因子:
7.3
作者:
Aurelio, Luigi;Scullino, Carmen V.;Flynn, Bernard L.
通讯作者:
Flynn, Bernard L.